29.61 428.62 Earnings (deficit) per share (Baht) 0.07 0.97 The company would like to explain the causes of changes as follows: 1. Sales revenues were decreased by 273.07 million baht or 2.93% from
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
expenses 6.73 0.30% 4.88 0.27% 1.85 37.91 Share of losses from associates 0.27 0.01% 0.00 0.00% 0.27 100.00 Income tax 20.77 0.94% 26.23 1.43% -5.46 -20.82 Net profit 43.95 1.98% 113.72 6.21% -69.77 -61.35
amounted to Baht 70. 00 million with net share premium of Baht 503. 33 million. • Total comprehensive income for 9 months Baht 43.42 million. • Dividend paid Baht 16.80 million. P a g e 3 | 7 The analysis of
amounted to Baht 70. 00 million with net share premium of Baht 503. 33 million. • Total comprehensive income for 9 months Baht 43.42 million. • Dividend paid Baht 16.80 million. P a g e 3 | 8 The analysis of
-113.3% Financial expenses -0.66 -1.16 0.50 -43.1% Share of income from investment in associate 0.09 0.52 -0.43 -82.7% Income tax expenses 0.82 -6.58 7.40 -112.5% Net profit for the period -4.40 27.71
the 1st quarter was 104.8 million baht decrease 11.4 %. Net profit margin equal to 3.9% equivalent to the ratio of earning per share to 0.116 the decrease was a result of the economic slowdown and the
+166% Share of profit (loss) from investments in JV (3) (4) +21% (14) (11) -26% Tax expenses (income) (34) 20 -277% (57) 61 -194% Profit (loss) attributable to equity holders of the parent (124) 78 -260
% Finance costs 14 17 -17% 66 60 +10% Share of profit (loss) from investment in subsidiaries and joint ventures (8) (0) -5374% (12) (16) +28% Tax (income) (17) (48) +65% (66) (101) +35% Net profit (loss
% % Administrative Expenses to Sales** 10.6% 9.6% - 10.6% 8.8% Finance Costs 17 6 +184% 60 22 +171% Share of profit (loss) from investments in JV (0.1) (11) +99% (15) (22) +34% Tax expenses (income) (48) (15) -231